# Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)

> **NCT00084266** · PHASE4 · COMPLETED · sponsor: **Pfizer** · enrollment: 1225 (actual)

## Conditions studied

- Methicillin Resistant Staphylococcus Aureus (MRSA)

## Interventions

- **DRUG:** linezolid (Zyvox)
- **DRUG:** vancomycin

## Key facts

- **NCT ID:** NCT00084266
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 1225 (ACTUAL)
- **Last updated:** 2012-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00084266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00084266, "Nosocomial Pneumonia With Suspected Or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00084266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*